Captor Capital Corp. (CPTR) Stock Analysis | Price, Returns, Financials & Key Metrics

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

12.0 k

Shareholding (Sep 2020)

FII

0.35%

Held by 2 FIIs

DII

99.65%

Held by 0 DIIs

Promoter

0.00%

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Dashboard

Flat results in Dec 24

PRE-TAX PROFIT(Q) At CAD 1.74 has Fallen at -75.62%
NET PROFIT(Q) At CAD 1.74 MM has Fallen at -77.03%
OPERATING CASH FLOW(Y) Lowest at CAD -5.67 MM

With ROE of 68.68%, it has a very attractive valuation with a 0.06 Price to Book Value

Consistent Underperformance against the benchmark over the last 3 years

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CAD 1 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

-0.92

Return on Equity

-168.57%

Price to Book

0.08

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2025)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

147.71%

6 Months

204.74%

1 Year

-22.86%

2 Years

-84.94%

3 Years

-43.75%

4 Years

650.0%

5 Years

650.0%

Captor Capital Corp. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

-100.00%

EBIT Growth (5y)

9.55%

EBIT to Interest (avg)

-4.02

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

-0.30

Sales to Capital Employed (avg)

2.04

Tax Ratio

19.33%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

0.35%

ROCE (avg)

ROE (avg)

14.55%

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.08

EV to EBIT

3.84

EV to EBITDA

3.84

EV to Capital Employed

-10.64

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

Negative Capital Employed

ROE (Latest)

-168.57%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Sep 2020

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 2 Foreign Institutions (0.35%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2025 is 96.10% vs -1,458.82% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'25",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-0.50",
          "val2": "-1.40",
          "chgp": "64.29%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.90",
          "val2": "-23.10",
          "chgp": "96.10%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -100.00% vs -11.96% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 147.83% vs 6.40% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "36.80",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.10",
          "val2": "2.40",
          "chgp": "-229.17%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.90",
          "chgp": "-100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "-11.70",
          "chgp": "100.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "7.70",
          "val2": "-16.10",
          "chgp": "147.83%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "-4.70%",
          "chgp": "0.47%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ

Jun'25

Mar'25

Change(%)

Net Sales

0.00

Operating Profit (PBDIT) excl Other Income

-0.50

-1.40

64.29%

Interest

0.00

Exceptional Items

0.00

Consolidate Net Profit

-0.90

-23.10

96.10%

Operating Profit Margin (Excl OI)

0.00%

USD in Million.

Compare with Peers

Net Sales

QoQ Growth in quarter ended Jun 2025 is 0.00% vs 0.00% in Mar 2025

Consolidated Net Profit

QoQ Growth in quarter ended Jun 2025 is 96.10% vs -1,458.82% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

0.00

36.80

-100.00%

Operating Profit (PBDIT) excl Other Income

-3.10

2.40

-229.17%

Interest

0.00

0.90

-100.00%

Exceptional Items

0.00

-11.70

100.00%

Consolidate Net Profit

7.70

-16.10

147.83%

Operating Profit Margin (Excl OI)

0.00%

-4.70%

0.47%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is -100.00% vs -11.96% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 147.83% vs 6.40% in Mar 2024

All Annual Results

Company CV

About Captor Capital Corp.

Captor Capital Corp.

Pharmaceuticals & Biotechnology

Captor Capital Corp is a Canada-based vertically integrated cannabis company. The Company is a producer and marketer of superior cannabis for recreational and medical use. It provides recreational and medical marijuana based products to consumers through its brands, dispensaries and retail stores. Its primary focus is to provide customers with access to a wide selection of products. By owning and operating its growing and processing facilities, the Company can ensure the safety of its products from harmful chemicals and other contaminants. The Company operates its wholly owned brands, such as Mellow Extracts and Chai, and it partners up with cannabis brands such as MedMen with a view to operate some of its facilities.

Company Coordinates

Company Details

4 King St W Suite 401 , TORONTO ON : M5H 1B6

Tel: 1 416 5043978

http://www.captorcapital.com/

Registrar Details